🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

$ANVS reports Q3 2024 financial results and provides business update. See full release via the link: annovisbio.com/press-release/…

Tune in today as Maria Maccecchini, Ph.D., CEO of $ANVS, will present at the The National Institute on Aging (NIA) workshop on #DementiaWithLewyBodies. For more details about the workshop and how to watch it online, see full release: annovisbio.com/press-release/…

$ANVS will host a year-end webcast on December 11, at 4:30 pm EST. Find more information and registration link in our news release: annovisbio.com/press-release/… #AnnovisBio #buntanetap #Alzheimers #Parkinsons #dementia #biotech

As the season ends, we’re excited to reflect on key milestones #AnnovisBio achieved this fall. Our recent progress has paved the way for an impactful year ahead. We thank all our supporters and will continue to share updates as we move forward in 2025. #Alzheimers #Parkinsons

As we celebrate this holiday season, we want to express our gratitude to everyone who has supported us throughout the year. Your belief is the greatest gift. Team Annovis is wishing you and your loved ones a joyful holiday season!

We are excited to announce that the FDA has accepted the final protocol for our #pivotal Phase 3 #Alzheimers study, which will now include a single 6/18-month study instead of two separate trials. Click for more: annovisbio.com/press-release/… $ANVS #Annovis #clinicaltrials #biotech

We are proud to announce the granting of a U.S. patent for the use of #buntanetap in acute #brain and #nerve injuries. This patent complements our existing IP protection for acute indications in Europe, Japan, and beyond, now ensuring global coverage. 🔗annovisbio.com/press-release/…

Our Phase 3 #clinicaltrial of #buntanetap for early #AlzheimersDisease is officially underway, with the first two patients being entered today! Find more information at: annovisbio.com/press-release/… $ANVS #Alzheimers #AD #dementia

Join us next week for a live forum where our CEO, Maria Maccecchini, Ph.D, will answer questions from patients, families & caregivers. $ANVS 🔗 Register & learn more: annovisbio.com/press-release/…

Next week our CEO, Maria Maccecchini, Ph.D., will attend the 13th Alzheimer’s & Parkinson’s Drug Development Summit where she will join a panel discussion on a new era for #Parkinsons treatment. $ANVS #buntanetap #Annovis For details, click annovisbio.com/press-release/…

New WTR Biotech Spotlight Episode Featuring Annovis Bio Listen to the full episode at the links below! Apple: podcasts.apple.com/us/podcast/ann… Spotify: open.spotify.com/episode/0Q0uaG… Website: watertowerresearch.com/media-detail/1… $ANVS #Alzheimers #Parkinsons #Biotech #Podcast #Investing

Next week, $ANVS is attending the #ADPD2025 in Vienna with several presentations and a forum participation. Find details at annovisbio.com/press-release/…

We’re excited to welcome Hui Liu to the Annovis team as our Director of Biostatistics! Her extensive expertise will play a key role as we advance toward our next milestones. Welcome aboard, Hui! 🔗annovisbio.com/press-release/… #biotech #annovis #alzheimers

$ANVS announces corporate updates and Q1, 2025 financial results. See full release at globenewswire.com/news-release/2… #biotech #clinicaltrials #alzheimers

Join $ANVS on June 24 for a live webinar and Q&A with our President and CEO, Maria Maccecchini, PhD. We encourage everyone to submit questions in advance. #alzheimers #parkinsons #biotech 🔗annovisbio.com/press-release/…

We are excited to welcome Kevin Snell as Site Engagement Lead! With 25+ years in clinical research, Mr. Snell will foster relationship with clinical sites and help drive the success of our pivotal Phase 3 #Alzheimers trial. Welcome aboard! #clinicaltrials #biotech #dementia

🧠 June is Alzheimer’s & Brain Awareness Month! Hard truth: millions still live without effective treatment. At Annovis, we're committed to brining real solution to patients by restoring cognition and hope. #AlzheimersAwareness #EndAlzheimers #BrainHealth

$ANVS is excited to attend the #AAIC2025 conference in Toronto, July 27-31, with four poster presentations. See you there! 🔗annovisbio.com/press-release/… #Alzheimers #AlzheimersDisease #AAIC25 Alzheimer's Association